The invention provides a complex which comprises at least one chromium ion and at least one pyridyl carboxylic acid moiety. The compounds of the invention are of use in controlling body mass and treating diseases caused by or characterized by deficiency of chromium metabolism, e.g, type 2 Diabetes, obesity, vascular disease and metabolic syndromes.